Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Biologics
•
Allergy & Immunology
•
Pulmonology
•
Obstructive Lung Disease
•
Asthma
•
Primary Care
How do you step down therapy in a patient with severe asthma on biologic therapy?
Related Questions
Should in-office oscillometry for lung function measurements be utilized in pediatric patients who are unable to reliably perform spirometry?
Do you feel high dose Symbicort or Dulera is appropriate to use for SMART despite these doses not being studied in clinical trials?
What is your approach to de-escalation of asthma inhaler therapy in the setting of negative bronchoprovocation testing when patients are averse to deprescribing?
What is your preferred biologic in children and adolescents with T2 high asthma?
Have you observed adverse mental health side effects in patients who start montelukast?
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?
What is the rationale/evidence to support doing 4 puffs of albuterol vs. 2 puffs for a reversibility study?
Do you utilize cytokine panels to guide treatment of patients with EGPA?
Do you routinely consider evaluation for EDAC in patients with asthma or COPD on maximal inhaler therapy who have refractory symptoms?
What is your preferred rescue inhaler for patients with asthma?
